002821: Asymchem Laboratories (Tianjin) Co., Ltd. - Summary | Jitta

Asymchem Laboratories (Tianjin) Co., Ltd.

CHN:002821

Price
CN¥125.56
Loss Chance
47.5%
5.51JITTA SCORE
316.02%Over Jitta Line
Jitta Ranking
99 / 487
990 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (40)
Recent Business Performance (74)
Financial Strength (89)
Return to Shareholders (40)
Competitive Advantage (53)
Jitta Signs
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.51
316.02%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.